Oramed Pharmaceuticals Inc., a pharmaceutical company developing oral drug delivery systems, announced the treatment of the last patient in the …

Medality Medical LLC, a U.S.-based medical technology company, announced that it has received approval to commence human trials of its proprietary …

Oramed Pharmaceuticals Inc., a company developing of oral drug delivery systems, announced today that its Chinese partner, Hefei Tianhui Incubator …

Aerpio Pharmaceuticals, a company focused on developing drugs to treat ocular diseases and diabetic complications, today announced top-line results …

Xeris Pharmaceuticals, Inc. announced it has begun dosing patients in a Phase 2 trial with its ready-to-use, room-temperature stable liquid glucagon …

AstraZeneca’s drug Brilinta® met primary endpoints in Phase 3 trials, the company reported on Monday. The trials showed that Brilinta …

StimLabs, a regenerative technology company announced that the first patient has been enrolled in the company’s clinical trial assessing the …

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases …

What you need to know about being part of a diabetes research study.